Beyond the direct effects of CPT1A on tumor cells, it was recently reported that CPT1A is secreted by tumor cells in the blood stream and detected as a serum biomarker for breast cancer diagnosis and progression [188]. The gene discussed is CPT1A; the disease is breast carcinoma.